Zhendong Liu Selected Research

Zhendong Liu Research Topics

Disease

25	Neoplasms (Cancer) 05/2022 - 01/2011
24	Glioma (Gliomas) 09/2022 - 03/2016
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2007
4	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 10/2018
4	Carcinogenesis 04/2021 - 07/2015
4	Hypertension (High Blood Pressure) 01/2021 - 06/2013
3	Hypoxia (Hypoxemia) 02/2021 - 07/2015
3	Ischemic Stroke 01/2021 - 11/2018
3	Cerebral Small Vessel Diseases 01/2020 - 11/2018
3	Osteosarcoma (Osteogenic Sarcoma) 08/2018 - 01/2017
2	Pathologic Processes 05/2022 - 01/2021
2	Brain Neoplasms (Brain Tumor) 02/2022 - 01/2020
2	Osteoporosis 01/2022 - 07/2018
2	Inflammation (Inflammations) 07/2021 - 05/2021
2	Neoplasm Metastasis (Metastasis) 05/2021 - 01/2017
2	Cognitive Dysfunction 01/2020 - 01/2019
2	Carcinoma (Carcinomatosis) 03/2019 - 07/2018
2	Abdominal Obesity 01/2018 - 02/2015
1	Immune System Diseases (Immune Disorders) 05/2022
1	Retinoblastoma (Glioblastoma, Retinal) 02/2022
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Genomic Instability 10/2021
1	Sepsis (Septicemia) 07/2021
1	Hepatocellular Carcinoma (Hepatoma) 05/2021
1	Starvation 02/2021
1	Heart Failure 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Myocardial Infarction 01/2021

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2020
7	Proteins (Proteins, Gene)FDA Link 05/2022 - 08/2018
5	Messenger RNA (mRNA)IBA 02/2022 - 10/2009
4	Biological ProductsIBA 10/2021 - 01/2021
4	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 03/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 03/2014
4	Telmisartan (Micardis)FDA Link 01/2020 - 03/2014
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2021 - 01/2020
3	MicroRNAs (MicroRNA)IBA 04/2021 - 08/2017
3	Long Noncoding RNAIBA 04/2021 - 05/2017
3	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2011
2	extracellular matrix receptorIBA 05/2022 - 02/2022
2	Carrier Proteins (Binding Protein)IBA 02/2022 - 10/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2018
2	CytokinesIBA 07/2021 - 03/2012
2	FlavonoidsIBA 05/2021 - 03/2016
2	Competitive Endogenous RNAIBA 04/2021 - 01/2020
2	Therapeutic UsesIBA 02/2021 - 03/2016
2	Doxazosin (Cardura)FDA LinkGeneric 01/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2020 - 11/2018
2	ApolipoproteinsIBA 01/2020 - 11/2018
2	Chloroquine (Aralen)FDA LinkGeneric 05/2019 - 10/2018
2	antrodin CIBA 03/2019 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 07/2015
2	Ephrin-A3 (Ephrin A3)IBA 05/2017 - 07/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2022
1	Lysine (L-Lysine)FDA Link 05/2022
1	AcetyltransferasesIBA 03/2022
1	piperlongumineIBA 02/2022
1	Cysteine (L-Cysteine)FDA Link 02/2022
1	Cathepsin CIBA 02/2022
1	ScopoletinIBA 02/2022
1	CathepsinsIBA 02/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2022
1	Indicators and Reagents (Reagents)IBA 02/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	HexestrolIBA 01/2022
1	cordycepinIBA 01/2022
1	HesperidinIBA 01/2022
1	Metal-Organic FrameworksIBA 12/2021
1	PorphyrinsIBA 12/2021
1	CollagenIBA 11/2021
1	Heat Shock Transcription FactorsIBA 10/2021
1	Cell Adhesion MoleculesIBA 06/2021
1	GTP-Binding Proteins (G-Protein)IBA 06/2021
1	Antisense RNA (Anti-Sense RNA)IBA 04/2021
1	Interleukin-1 Receptor-Associated KinasesIBA 04/2021
1	gluconic acid (gluconate)FDA LinkGeneric 02/2021
1	AntioxidantsIBA 02/2021
1	CatalaseIBA 02/2021
1	Glutathione (Reduced Glutathione)IBA 02/2021
1	AntigensIBA 01/2021
1	Thioguanine (Tioguanine)FDA Link 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	Proto-Oncogene Proteins c-etsIBA 01/2021
1	EmetineIBA 01/2021
1	LipidsIBA 01/2021
1	Tirofiban (Aggrastat)FDA Link 01/2021
1	CarbohydratesIBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	chrysinIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021

Therapy/Procedure

12	Therapeutics 03/2022 - 03/2016
5	Drug Therapy (Chemotherapy) 11/2021 - 08/2018
2	Immunotherapy 02/2022 - 02/2022
1	Thrombectomy 01/2021
1	Laminectomy 01/2021